TLN-254
/ Treeline Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 25, 2025
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
(clinicaltrials.gov)
- P1 | N=180 | Recruiting | Sponsor: Treeline Biosciences, Inc.
New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
December 26, 2024
TLN-254-2401: A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
(clinicaltrials.gov)
- P1 | N=50 | Recruiting | Sponsor: Treeline Biosciences, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma
December 13, 2024
TLN-254-2401: A Study of TLN-254 in Participants with Relapsed or Refractory T-cell Lymphoma
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Treeline Biosciences, Inc.
New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma
1 to 3
Of
3
Go to page
1